ALK and lung adenocarcinoma: We did not find evidence that 9p21 loss is associated with a “cold” tumor-immune phenotype in our study which was focused on EGFR/ALK- lung adenocarcinoma specimens and acknowledge that there are potentially significant tumor type differences in this relationship that need to be explored.